AKT1 and cholangiocarcinoma: These findings suggest that AZGP1, secreted in response to 5-FU treatment in CCA, interacts with the extracellular domain of PD-L1, thereby activating the AKT signaling pathway and ultimately leading to cell death in CCA cell lines.